2
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

2
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Non-invasive Preimplantation Genetic Testing Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-5R15711
Home | Market Reports | Health| Reproductive Health
Global Non invasive Preimplantation Genetic Testing Market Research Report 2023
BUY CHAPTERS

Global Non-invasive Preimplantation Genetic Testing Market Research Report 2025

Code: QYRE-Auto-5R15711
Report
May 2025
Pages:100
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Non-invasive Preimplantation Genetic Testing Market

The global market for Non-invasive Preimplantation Genetic Testing was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Non-invasive preimplantation genetic testing (NI-PGT) is a technique used in assisted reproductive technology (ART) to assess the genetic makeup of embryos before they are implanted into the uterus during in vitro fertilization (IVF).
North American market for Non-invasive Preimplantation Genetic Testing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Non-invasive Preimplantation Genetic Testing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Non-invasive Preimplantation Genetic Testing include Illumina, Thermo Fisher Scientific, Agilent, Revvity, The Cooper Companies, Abbott, TAKARA, QIAGEN, Vitrolife, Oxford Nanopore Technologies, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Non-invasive Preimplantation Genetic Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-invasive Preimplantation Genetic Testing.
The Non-invasive Preimplantation Genetic Testing market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Non-invasive Preimplantation Genetic Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Non-invasive Preimplantation Genetic Testing manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Non-invasive Preimplantation Genetic Testing Market Report

Report Metric Details
Report Name Non-invasive Preimplantation Genetic Testing Market
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Illumina, Thermo Fisher Scientific, Agilent, Revvity, The Cooper Companies, Abbott, TAKARA, QIAGEN, Vitrolife, Oxford Nanopore Technologies, Yikon Genomics, Shiva Scientific, Medicover Genetics, MedGenome, Fulgent, INVICTA GENETICS, Genea Fertility, Bioarray, GeneMind Biosciences, Unimed Biotech
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Non-invasive Preimplantation Genetic Testing manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Non-invasive Preimplantation Genetic Testing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Non-invasive Preimplantation Genetic Testing Market report?

Ans: The main players in the Non-invasive Preimplantation Genetic Testing Market are Illumina, Thermo Fisher Scientific, Agilent, Revvity, The Cooper Companies, Abbott, TAKARA, QIAGEN, Vitrolife, Oxford Nanopore Technologies, Yikon Genomics, Shiva Scientific, Medicover Genetics, MedGenome, Fulgent, INVICTA GENETICS, Genea Fertility, Bioarray, GeneMind Biosciences, Unimed Biotech

What are the Application segmentation covered in the Non-invasive Preimplantation Genetic Testing Market report?

Ans: The Applications covered in the Non-invasive Preimplantation Genetic Testing Market report are Hospitals, Diagnostic Laboratories, Other

What are the Type segmentation covered in the Non-invasive Preimplantation Genetic Testing Market report?

Ans: The Types covered in the Non-invasive Preimplantation Genetic Testing Market report are Preimplantation Genetic Screening, Preimplantation Genetic Diagnosis

Recommended Reports

Prenatal & Preimplantation

Non-Invasive Diagnostics

Genetic Testing Devices

1 Non-invasive Preimplantation Genetic Testing Market Overview
1.1 Product Definition
1.2 Non-invasive Preimplantation Genetic Testing by Type
1.2.1 Global Non-invasive Preimplantation Genetic Testing Market Value Comparison by Type (2024 VS 2031)
1.2.2 Preimplantation Genetic Screening
1.2.3 Preimplantation Genetic Diagnosis
1.3 Non-invasive Preimplantation Genetic Testing by Application
1.3.1 Global Non-invasive Preimplantation Genetic Testing Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Diagnostic Laboratories
1.3.4 Other
1.4 Global Non-invasive Preimplantation Genetic Testing Market Size Estimates and Forecasts
1.4.1 Global Non-invasive Preimplantation Genetic Testing Revenue 2020-2031
1.4.2 Global Non-invasive Preimplantation Genetic Testing Sales 2020-2031
1.4.3 Global Non-invasive Preimplantation Genetic Testing Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Non-invasive Preimplantation Genetic Testing Market Competition by Manufacturers
2.1 Global Non-invasive Preimplantation Genetic Testing Sales Market Share by Manufacturers (2020-2025)
2.2 Global Non-invasive Preimplantation Genetic Testing Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Non-invasive Preimplantation Genetic Testing Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Non-invasive Preimplantation Genetic Testing, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Non-invasive Preimplantation Genetic Testing, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Non-invasive Preimplantation Genetic Testing, Product Type & Application
2.7 Global Key Manufacturers of Non-invasive Preimplantation Genetic Testing, Date of Enter into This Industry
2.8 Global Non-invasive Preimplantation Genetic Testing Market Competitive Situation and Trends
2.8.1 Global Non-invasive Preimplantation Genetic Testing Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Non-invasive Preimplantation Genetic Testing Players Market Share by Revenue
2.8.3 Global Non-invasive Preimplantation Genetic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Non-invasive Preimplantation Genetic Testing Market Scenario by Region
3.1 Global Non-invasive Preimplantation Genetic Testing Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Non-invasive Preimplantation Genetic Testing Sales by Region: 2020-2031
3.2.1 Global Non-invasive Preimplantation Genetic Testing Sales by Region: 2020-2025
3.2.2 Global Non-invasive Preimplantation Genetic Testing Sales by Region: 2026-2031
3.3 Global Non-invasive Preimplantation Genetic Testing Revenue by Region: 2020-2031
3.3.1 Global Non-invasive Preimplantation Genetic Testing Revenue by Region: 2020-2025
3.3.2 Global Non-invasive Preimplantation Genetic Testing Revenue by Region: 2026-2031
3.4 North America Non-invasive Preimplantation Genetic Testing Market Facts & Figures by Country
3.4.1 North America Non-invasive Preimplantation Genetic Testing Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Non-invasive Preimplantation Genetic Testing Sales by Country (2020-2031)
3.4.3 North America Non-invasive Preimplantation Genetic Testing Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Non-invasive Preimplantation Genetic Testing Market Facts & Figures by Country
3.5.1 Europe Non-invasive Preimplantation Genetic Testing Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Non-invasive Preimplantation Genetic Testing Sales by Country (2020-2031)
3.5.3 Europe Non-invasive Preimplantation Genetic Testing Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Non-invasive Preimplantation Genetic Testing Market Facts & Figures by Region
3.6.1 Asia Pacific Non-invasive Preimplantation Genetic Testing Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Non-invasive Preimplantation Genetic Testing Sales by Region (2020-2031)
3.6.3 Asia Pacific Non-invasive Preimplantation Genetic Testing Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Non-invasive Preimplantation Genetic Testing Market Facts & Figures by Country
3.7.1 Latin America Non-invasive Preimplantation Genetic Testing Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Non-invasive Preimplantation Genetic Testing Sales by Country (2020-2031)
3.7.3 Latin America Non-invasive Preimplantation Genetic Testing Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Non-invasive Preimplantation Genetic Testing Market Facts & Figures by Country
3.8.1 Middle East and Africa Non-invasive Preimplantation Genetic Testing Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Non-invasive Preimplantation Genetic Testing Sales by Country (2020-2031)
3.8.3 Middle East and Africa Non-invasive Preimplantation Genetic Testing Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Non-invasive Preimplantation Genetic Testing Sales by Type (2020-2031)
4.1.1 Global Non-invasive Preimplantation Genetic Testing Sales by Type (2020-2025)
4.1.2 Global Non-invasive Preimplantation Genetic Testing Sales by Type (2026-2031)
4.1.3 Global Non-invasive Preimplantation Genetic Testing Sales Market Share by Type (2020-2031)
4.2 Global Non-invasive Preimplantation Genetic Testing Revenue by Type (2020-2031)
4.2.1 Global Non-invasive Preimplantation Genetic Testing Revenue by Type (2020-2025)
4.2.2 Global Non-invasive Preimplantation Genetic Testing Revenue by Type (2026-2031)
4.2.3 Global Non-invasive Preimplantation Genetic Testing Revenue Market Share by Type (2020-2031)
4.3 Global Non-invasive Preimplantation Genetic Testing Price by Type (2020-2031)
5 Segment by Application
5.1 Global Non-invasive Preimplantation Genetic Testing Sales by Application (2020-2031)
5.1.1 Global Non-invasive Preimplantation Genetic Testing Sales by Application (2020-2025)
5.1.2 Global Non-invasive Preimplantation Genetic Testing Sales by Application (2026-2031)
5.1.3 Global Non-invasive Preimplantation Genetic Testing Sales Market Share by Application (2020-2031)
5.2 Global Non-invasive Preimplantation Genetic Testing Revenue by Application (2020-2031)
5.2.1 Global Non-invasive Preimplantation Genetic Testing Revenue by Application (2020-2025)
5.2.2 Global Non-invasive Preimplantation Genetic Testing Revenue by Application (2026-2031)
5.2.3 Global Non-invasive Preimplantation Genetic Testing Revenue Market Share by Application (2020-2031)
5.3 Global Non-invasive Preimplantation Genetic Testing Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Illumina
6.1.1 Illumina Company Information
6.1.2 Illumina Description and Business Overview
6.1.3 Illumina Non-invasive Preimplantation Genetic Testing Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Illumina Non-invasive Preimplantation Genetic Testing Product Portfolio
6.1.5 Illumina Recent Developments/Updates
6.2 Thermo Fisher Scientific
6.2.1 Thermo Fisher Scientific Company Information
6.2.2 Thermo Fisher Scientific Description and Business Overview
6.2.3 Thermo Fisher Scientific Non-invasive Preimplantation Genetic Testing Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Thermo Fisher Scientific Non-invasive Preimplantation Genetic Testing Product Portfolio
6.2.5 Thermo Fisher Scientific Recent Developments/Updates
6.3 Agilent
6.3.1 Agilent Company Information
6.3.2 Agilent Description and Business Overview
6.3.3 Agilent Non-invasive Preimplantation Genetic Testing Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Agilent Non-invasive Preimplantation Genetic Testing Product Portfolio
6.3.5 Agilent Recent Developments/Updates
6.4 Revvity
6.4.1 Revvity Company Information
6.4.2 Revvity Description and Business Overview
6.4.3 Revvity Non-invasive Preimplantation Genetic Testing Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Revvity Non-invasive Preimplantation Genetic Testing Product Portfolio
6.4.5 Revvity Recent Developments/Updates
6.5 The Cooper Companies
6.5.1 The Cooper Companies Company Information
6.5.2 The Cooper Companies Description and Business Overview
6.5.3 The Cooper Companies Non-invasive Preimplantation Genetic Testing Sales, Revenue and Gross Margin (2020-2025)
6.5.4 The Cooper Companies Non-invasive Preimplantation Genetic Testing Product Portfolio
6.5.5 The Cooper Companies Recent Developments/Updates
6.6 Abbott
6.6.1 Abbott Company Information
6.6.2 Abbott Description and Business Overview
6.6.3 Abbott Non-invasive Preimplantation Genetic Testing Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Abbott Non-invasive Preimplantation Genetic Testing Product Portfolio
6.6.5 Abbott Recent Developments/Updates
6.7 TAKARA
6.7.1 TAKARA Company Information
6.7.2 TAKARA Description and Business Overview
6.7.3 TAKARA Non-invasive Preimplantation Genetic Testing Sales, Revenue and Gross Margin (2020-2025)
6.7.4 TAKARA Non-invasive Preimplantation Genetic Testing Product Portfolio
6.7.5 TAKARA Recent Developments/Updates
6.8 QIAGEN
6.8.1 QIAGEN Company Information
6.8.2 QIAGEN Description and Business Overview
6.8.3 QIAGEN Non-invasive Preimplantation Genetic Testing Sales, Revenue and Gross Margin (2020-2025)
6.8.4 QIAGEN Non-invasive Preimplantation Genetic Testing Product Portfolio
6.8.5 QIAGEN Recent Developments/Updates
6.9 Vitrolife
6.9.1 Vitrolife Company Information
6.9.2 Vitrolife Description and Business Overview
6.9.3 Vitrolife Non-invasive Preimplantation Genetic Testing Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Vitrolife Non-invasive Preimplantation Genetic Testing Product Portfolio
6.9.5 Vitrolife Recent Developments/Updates
6.10 Oxford Nanopore Technologies
6.10.1 Oxford Nanopore Technologies Company Information
6.10.2 Oxford Nanopore Technologies Description and Business Overview
6.10.3 Oxford Nanopore Technologies Non-invasive Preimplantation Genetic Testing Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Oxford Nanopore Technologies Non-invasive Preimplantation Genetic Testing Product Portfolio
6.10.5 Oxford Nanopore Technologies Recent Developments/Updates
6.11 Yikon Genomics
6.11.1 Yikon Genomics Company Information
6.11.2 Yikon Genomics Description and Business Overview
6.11.3 Yikon Genomics Non-invasive Preimplantation Genetic Testing Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Yikon Genomics Non-invasive Preimplantation Genetic Testing Product Portfolio
6.11.5 Yikon Genomics Recent Developments/Updates
6.12 Shiva Scientific
6.12.1 Shiva Scientific Company Information
6.12.2 Shiva Scientific Description and Business Overview
6.12.3 Shiva Scientific Non-invasive Preimplantation Genetic Testing Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Shiva Scientific Non-invasive Preimplantation Genetic Testing Product Portfolio
6.12.5 Shiva Scientific Recent Developments/Updates
6.13 Medicover Genetics
6.13.1 Medicover Genetics Company Information
6.13.2 Medicover Genetics Description and Business Overview
6.13.3 Medicover Genetics Non-invasive Preimplantation Genetic Testing Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Medicover Genetics Non-invasive Preimplantation Genetic Testing Product Portfolio
6.13.5 Medicover Genetics Recent Developments/Updates
6.14 MedGenome
6.14.1 MedGenome Company Information
6.14.2 MedGenome Description and Business Overview
6.14.3 MedGenome Non-invasive Preimplantation Genetic Testing Sales, Revenue and Gross Margin (2020-2025)
6.14.4 MedGenome Non-invasive Preimplantation Genetic Testing Product Portfolio
6.14.5 MedGenome Recent Developments/Updates
6.15 Fulgent
6.15.1 Fulgent Company Information
6.15.2 Fulgent Description and Business Overview
6.15.3 Fulgent Non-invasive Preimplantation Genetic Testing Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Fulgent Non-invasive Preimplantation Genetic Testing Product Portfolio
6.15.5 Fulgent Recent Developments/Updates
6.16 INVICTA GENETICS
6.16.1 INVICTA GENETICS Company Information
6.16.2 INVICTA GENETICS Description and Business Overview
6.16.3 INVICTA GENETICS Non-invasive Preimplantation Genetic Testing Sales, Revenue and Gross Margin (2020-2025)
6.16.4 INVICTA GENETICS Non-invasive Preimplantation Genetic Testing Product Portfolio
6.16.5 INVICTA GENETICS Recent Developments/Updates
6.17 Genea Fertility
6.17.1 Genea Fertility Company Information
6.17.2 Genea Fertility Description and Business Overview
6.17.3 Genea Fertility Non-invasive Preimplantation Genetic Testing Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Genea Fertility Non-invasive Preimplantation Genetic Testing Product Portfolio
6.17.5 Genea Fertility Recent Developments/Updates
6.18 Bioarray
6.18.1 Bioarray Company Information
6.18.2 Bioarray Description and Business Overview
6.18.3 Bioarray Non-invasive Preimplantation Genetic Testing Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Bioarray Non-invasive Preimplantation Genetic Testing Product Portfolio
6.18.5 Bioarray Recent Developments/Updates
6.19 GeneMind Biosciences
6.19.1 GeneMind Biosciences Company Information
6.19.2 GeneMind Biosciences Description and Business Overview
6.19.3 GeneMind Biosciences Non-invasive Preimplantation Genetic Testing Sales, Revenue and Gross Margin (2020-2025)
6.19.4 GeneMind Biosciences Non-invasive Preimplantation Genetic Testing Product Portfolio
6.19.5 GeneMind Biosciences Recent Developments/Updates
6.20 Unimed Biotech
6.20.1 Unimed Biotech Company Information
6.20.2 Unimed Biotech Description and Business Overview
6.20.3 Unimed Biotech Non-invasive Preimplantation Genetic Testing Sales, Revenue and Gross Margin (2020-2025)
6.20.4 Unimed Biotech Non-invasive Preimplantation Genetic Testing Product Portfolio
6.20.5 Unimed Biotech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Non-invasive Preimplantation Genetic Testing Industry Chain Analysis
7.2 Non-invasive Preimplantation Genetic Testing Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Non-invasive Preimplantation Genetic Testing Production Mode & Process Analysis
7.4 Non-invasive Preimplantation Genetic Testing Sales and Marketing
7.4.1 Non-invasive Preimplantation Genetic Testing Sales Channels
7.4.2 Non-invasive Preimplantation Genetic Testing Distributors
7.5 Non-invasive Preimplantation Genetic Testing Customer Analysis
8 Non-invasive Preimplantation Genetic Testing Market Dynamics
8.1 Non-invasive Preimplantation Genetic Testing Industry Trends
8.2 Non-invasive Preimplantation Genetic Testing Market Drivers
8.3 Non-invasive Preimplantation Genetic Testing Market Challenges
8.4 Non-invasive Preimplantation Genetic Testing Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Non-invasive Preimplantation Genetic Testing Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Non-invasive Preimplantation Genetic Testing Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Non-invasive Preimplantation Genetic Testing Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Non-invasive Preimplantation Genetic Testing Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Non-invasive Preimplantation Genetic Testing Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Non-invasive Preimplantation Genetic Testing Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Non-invasive Preimplantation Genetic Testing Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Non-invasive Preimplantation Genetic Testing Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Non-invasive Preimplantation Genetic Testing, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Non-invasive Preimplantation Genetic Testing, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Non-invasive Preimplantation Genetic Testing, Product Type & Application
 Table 12. Global Key Manufacturers of Non-invasive Preimplantation Genetic Testing, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Non-invasive Preimplantation Genetic Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-invasive Preimplantation Genetic Testing as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Non-invasive Preimplantation Genetic Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Non-invasive Preimplantation Genetic Testing Sales by Region (2020-2025) & (K Units)
 Table 18. Global Non-invasive Preimplantation Genetic Testing Sales Market Share by Region (2020-2025)
 Table 19. Global Non-invasive Preimplantation Genetic Testing Sales by Region (2026-2031) & (K Units)
 Table 20. Global Non-invasive Preimplantation Genetic Testing Sales Market Share by Region (2026-2031)
 Table 21. Global Non-invasive Preimplantation Genetic Testing Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Non-invasive Preimplantation Genetic Testing Revenue Market Share by Region (2020-2025)
 Table 23. Global Non-invasive Preimplantation Genetic Testing Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Non-invasive Preimplantation Genetic Testing Revenue Market Share by Region (2026-2031)
 Table 25. North America Non-invasive Preimplantation Genetic Testing Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Non-invasive Preimplantation Genetic Testing Sales by Country (2020-2025) & (K Units)
 Table 27. North America Non-invasive Preimplantation Genetic Testing Sales by Country (2026-2031) & (K Units)
 Table 28. North America Non-invasive Preimplantation Genetic Testing Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Non-invasive Preimplantation Genetic Testing Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Non-invasive Preimplantation Genetic Testing Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Non-invasive Preimplantation Genetic Testing Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Non-invasive Preimplantation Genetic Testing Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Non-invasive Preimplantation Genetic Testing Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Non-invasive Preimplantation Genetic Testing Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Non-invasive Preimplantation Genetic Testing Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Non-invasive Preimplantation Genetic Testing Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Non-invasive Preimplantation Genetic Testing Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Non-invasive Preimplantation Genetic Testing Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Non-invasive Preimplantation Genetic Testing Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Non-invasive Preimplantation Genetic Testing Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Non-invasive Preimplantation Genetic Testing Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Non-invasive Preimplantation Genetic Testing Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Non-invasive Preimplantation Genetic Testing Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Non-invasive Preimplantation Genetic Testing Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Non-invasive Preimplantation Genetic Testing Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Non-invasive Preimplantation Genetic Testing Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Non-invasive Preimplantation Genetic Testing Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Non-invasive Preimplantation Genetic Testing Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Non-invasive Preimplantation Genetic Testing Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Non-invasive Preimplantation Genetic Testing Sales (K Units) by Type (2020-2025)
 Table 51. Global Non-invasive Preimplantation Genetic Testing Sales (K Units) by Type (2026-2031)
 Table 52. Global Non-invasive Preimplantation Genetic Testing Sales Market Share by Type (2020-2025)
 Table 53. Global Non-invasive Preimplantation Genetic Testing Sales Market Share by Type (2026-2031)
 Table 54. Global Non-invasive Preimplantation Genetic Testing Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Non-invasive Preimplantation Genetic Testing Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Non-invasive Preimplantation Genetic Testing Revenue Market Share by Type (2020-2025)
 Table 57. Global Non-invasive Preimplantation Genetic Testing Revenue Market Share by Type (2026-2031)
 Table 58. Global Non-invasive Preimplantation Genetic Testing Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Non-invasive Preimplantation Genetic Testing Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Non-invasive Preimplantation Genetic Testing Sales (K Units) by Application (2020-2025)
 Table 61. Global Non-invasive Preimplantation Genetic Testing Sales (K Units) by Application (2026-2031)
 Table 62. Global Non-invasive Preimplantation Genetic Testing Sales Market Share by Application (2020-2025)
 Table 63. Global Non-invasive Preimplantation Genetic Testing Sales Market Share by Application (2026-2031)
 Table 64. Global Non-invasive Preimplantation Genetic Testing Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Non-invasive Preimplantation Genetic Testing Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Non-invasive Preimplantation Genetic Testing Revenue Market Share by Application (2020-2025)
 Table 67. Global Non-invasive Preimplantation Genetic Testing Revenue Market Share by Application (2026-2031)
 Table 68. Global Non-invasive Preimplantation Genetic Testing Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Non-invasive Preimplantation Genetic Testing Price (US$/Unit) by Application (2026-2031)
 Table 70. Illumina Company Information
 Table 71. Illumina Description and Business Overview
 Table 72. Illumina Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Illumina Non-invasive Preimplantation Genetic Testing Product
 Table 74. Illumina Recent Developments/Updates
 Table 75. Thermo Fisher Scientific Company Information
 Table 76. Thermo Fisher Scientific Description and Business Overview
 Table 77. Thermo Fisher Scientific Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Thermo Fisher Scientific Non-invasive Preimplantation Genetic Testing Product
 Table 79. Thermo Fisher Scientific Recent Developments/Updates
 Table 80. Agilent Company Information
 Table 81. Agilent Description and Business Overview
 Table 82. Agilent Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Agilent Non-invasive Preimplantation Genetic Testing Product
 Table 84. Agilent Recent Developments/Updates
 Table 85. Revvity Company Information
 Table 86. Revvity Description and Business Overview
 Table 87. Revvity Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Revvity Non-invasive Preimplantation Genetic Testing Product
 Table 89. Revvity Recent Developments/Updates
 Table 90. The Cooper Companies Company Information
 Table 91. The Cooper Companies Description and Business Overview
 Table 92. The Cooper Companies Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. The Cooper Companies Non-invasive Preimplantation Genetic Testing Product
 Table 94. The Cooper Companies Recent Developments/Updates
 Table 95. Abbott Company Information
 Table 96. Abbott Description and Business Overview
 Table 97. Abbott Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Abbott Non-invasive Preimplantation Genetic Testing Product
 Table 99. Abbott Recent Developments/Updates
 Table 100. TAKARA Company Information
 Table 101. TAKARA Description and Business Overview
 Table 102. TAKARA Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. TAKARA Non-invasive Preimplantation Genetic Testing Product
 Table 104. TAKARA Recent Developments/Updates
 Table 105. QIAGEN Company Information
 Table 106. QIAGEN Description and Business Overview
 Table 107. QIAGEN Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. QIAGEN Non-invasive Preimplantation Genetic Testing Product
 Table 109. QIAGEN Recent Developments/Updates
 Table 110. Vitrolife Company Information
 Table 111. Vitrolife Description and Business Overview
 Table 112. Vitrolife Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Vitrolife Non-invasive Preimplantation Genetic Testing Product
 Table 114. Vitrolife Recent Developments/Updates
 Table 115. Oxford Nanopore Technologies Company Information
 Table 116. Oxford Nanopore Technologies Description and Business Overview
 Table 117. Oxford Nanopore Technologies Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Oxford Nanopore Technologies Non-invasive Preimplantation Genetic Testing Product
 Table 119. Oxford Nanopore Technologies Recent Developments/Updates
 Table 120. Yikon Genomics Company Information
 Table 121. Yikon Genomics Description and Business Overview
 Table 122. Yikon Genomics Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Yikon Genomics Non-invasive Preimplantation Genetic Testing Product
 Table 124. Yikon Genomics Recent Developments/Updates
 Table 125. Shiva Scientific Company Information
 Table 126. Shiva Scientific Description and Business Overview
 Table 127. Shiva Scientific Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Shiva Scientific Non-invasive Preimplantation Genetic Testing Product
 Table 129. Shiva Scientific Recent Developments/Updates
 Table 130. Medicover Genetics Company Information
 Table 131. Medicover Genetics Description and Business Overview
 Table 132. Medicover Genetics Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Medicover Genetics Non-invasive Preimplantation Genetic Testing Product
 Table 134. Medicover Genetics Recent Developments/Updates
 Table 135. MedGenome Company Information
 Table 136. MedGenome Description and Business Overview
 Table 137. MedGenome Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. MedGenome Non-invasive Preimplantation Genetic Testing Product
 Table 139. MedGenome Recent Developments/Updates
 Table 140. Fulgent Company Information
 Table 141. Fulgent Description and Business Overview
 Table 142. Fulgent Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Fulgent Non-invasive Preimplantation Genetic Testing Product
 Table 144. Fulgent Recent Developments/Updates
 Table 145. INVICTA GENETICS Company Information
 Table 146. INVICTA GENETICS Description and Business Overview
 Table 147. INVICTA GENETICS Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 148. INVICTA GENETICS Non-invasive Preimplantation Genetic Testing Product
 Table 149. INVICTA GENETICS Recent Developments/Updates
 Table 150. Genea Fertility Company Information
 Table 151. Genea Fertility Description and Business Overview
 Table 152. Genea Fertility Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 153. Genea Fertility Non-invasive Preimplantation Genetic Testing Product
 Table 154. Genea Fertility Recent Developments/Updates
 Table 155. Bioarray Company Information
 Table 156. Bioarray Description and Business Overview
 Table 157. Bioarray Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 158. Bioarray Non-invasive Preimplantation Genetic Testing Product
 Table 159. Bioarray Recent Developments/Updates
 Table 160. GeneMind Biosciences Company Information
 Table 161. GeneMind Biosciences Description and Business Overview
 Table 162. GeneMind Biosciences Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 163. GeneMind Biosciences Non-invasive Preimplantation Genetic Testing Product
 Table 164. GeneMind Biosciences Recent Developments/Updates
 Table 165. Unimed Biotech Company Information
 Table 166. Unimed Biotech Description and Business Overview
 Table 167. Unimed Biotech Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 168. Unimed Biotech Non-invasive Preimplantation Genetic Testing Product
 Table 169. Unimed Biotech Recent Developments/Updates
 Table 170. Key Raw Materials Lists
 Table 171. Raw Materials Key Suppliers Lists
 Table 172. Non-invasive Preimplantation Genetic Testing Distributors List
 Table 173. Non-invasive Preimplantation Genetic Testing Customers List
 Table 174. Non-invasive Preimplantation Genetic Testing Market Trends
 Table 175. Non-invasive Preimplantation Genetic Testing Market Drivers
 Table 176. Non-invasive Preimplantation Genetic Testing Market Challenges
 Table 177. Non-invasive Preimplantation Genetic Testing Market Restraints
 Table 178. Research Programs/Design for This Report
 Table 179. Key Data Information from Secondary Sources
 Table 180. Key Data Information from Primary Sources
 Table 181. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Non-invasive Preimplantation Genetic Testing
 Figure 2. Global Non-invasive Preimplantation Genetic Testing Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Non-invasive Preimplantation Genetic Testing Market Share by Type: 2024 & 2031
 Figure 4. Preimplantation Genetic Screening Product Picture
 Figure 5. Preimplantation Genetic Diagnosis Product Picture
 Figure 6. Global Non-invasive Preimplantation Genetic Testing Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Non-invasive Preimplantation Genetic Testing Market Share by Application: 2024 & 2031
 Figure 8. Hospitals
 Figure 9. Diagnostic Laboratories
 Figure 10. Other
 Figure 11. Global Non-invasive Preimplantation Genetic Testing Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Non-invasive Preimplantation Genetic Testing Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Non-invasive Preimplantation Genetic Testing Sales (2020-2031) & (K Units)
 Figure 14. Global Non-invasive Preimplantation Genetic Testing Average Price (US$/Unit) & (2020-2031)
 Figure 15. Non-invasive Preimplantation Genetic Testing Report Years Considered
 Figure 16. Non-invasive Preimplantation Genetic Testing Sales Share by Manufacturers in 2024
 Figure 17. Global Non-invasive Preimplantation Genetic Testing Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Non-invasive Preimplantation Genetic Testing Players: Market Share by Revenue in Non-invasive Preimplantation Genetic Testing in 2024
 Figure 19. Non-invasive Preimplantation Genetic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Non-invasive Preimplantation Genetic Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Non-invasive Preimplantation Genetic Testing Sales Market Share by Country (2020-2031)
 Figure 22. North America Non-invasive Preimplantation Genetic Testing Revenue Market Share by Country (2020-2031)
 Figure 23. United States Non-invasive Preimplantation Genetic Testing Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Non-invasive Preimplantation Genetic Testing Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Non-invasive Preimplantation Genetic Testing Sales Market Share by Country (2020-2031)
 Figure 26. Europe Non-invasive Preimplantation Genetic Testing Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Non-invasive Preimplantation Genetic Testing Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Non-invasive Preimplantation Genetic Testing Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Non-invasive Preimplantation Genetic Testing Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Non-invasive Preimplantation Genetic Testing Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Non-invasive Preimplantation Genetic Testing Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Non-invasive Preimplantation Genetic Testing Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Non-invasive Preimplantation Genetic Testing Revenue Market Share by Region (2020-2031)
 Figure 34. China Non-invasive Preimplantation Genetic Testing Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Non-invasive Preimplantation Genetic Testing Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Non-invasive Preimplantation Genetic Testing Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Non-invasive Preimplantation Genetic Testing Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Non-invasive Preimplantation Genetic Testing Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Non-invasive Preimplantation Genetic Testing Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Non-invasive Preimplantation Genetic Testing Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America Non-invasive Preimplantation Genetic Testing Sales Market Share by Country (2020-2031)
 Figure 42. Latin America Non-invasive Preimplantation Genetic Testing Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico Non-invasive Preimplantation Genetic Testing Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil Non-invasive Preimplantation Genetic Testing Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina Non-invasive Preimplantation Genetic Testing Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Middle East and Africa Non-invasive Preimplantation Genetic Testing Sales Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa Non-invasive Preimplantation Genetic Testing Revenue Market Share by Country (2020-2031)
 Figure 48. Turkey Non-invasive Preimplantation Genetic Testing Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Non-invasive Preimplantation Genetic Testing Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. UAE Non-invasive Preimplantation Genetic Testing Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Global Sales Market Share of Non-invasive Preimplantation Genetic Testing by Type (2020-2031)
 Figure 52. Global Revenue Market Share of Non-invasive Preimplantation Genetic Testing by Type (2020-2031)
 Figure 53. Global Non-invasive Preimplantation Genetic Testing Price (US$/Unit) by Type (2020-2031)
 Figure 54. Global Sales Market Share of Non-invasive Preimplantation Genetic Testing by Application (2020-2031)
 Figure 55. Global Revenue Market Share of Non-invasive Preimplantation Genetic Testing by Application (2020-2031)
 Figure 56. Global Non-invasive Preimplantation Genetic Testing Price (US$/Unit) by Application (2020-2031)
 Figure 57. Non-invasive Preimplantation Genetic Testing Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS